Table 3.
Effect of Experiments on Seeum Bilirubin and SGOT at Sacrifice
Group | Description | Bilirubin (mg% sacrifice) |
pa | No. of dogs with bilirubin ≥1.2 mg/dl |
SGOT (mU/ml sacrifice) |
pa |
---|---|---|---|---|---|---|
1 | PCS | 1.1 ± 0.2 | 0/6 | 30 ±6 | — | |
2 | PCS + BF | 2.8 ± 1.8 | NSb | 5/10 | 45 ±31 | NS |
3 | PCS | 1.2 ± 0.7 | NS | 1/10 | 36 ± 30.6 | — |
4 | PCS + BF (staged) | <1 | NS | 0/5 | 49.2 ± 24 | NS |
5 | IB | 1.1 ± 0.2 | NS | 0/5 | 19.4 ± 17.4 | NS |
6 | PCS + IB | <1 | NS | 0/10 | 11.9 ± 8 | <0.05 |
7 | PCS + IB (staged) | 1.08 ± 0.2 | NS | 0/10 | 27.6 ± 14.5 | NS |
Statistical evaluations were: Group 2 vs. Group 1 (control) and Groups 4 to 7 vs. 3 (control). Bilirubin normal, <1.2 mg/dl; SGOT normal, ≤50 mU/ml.
NS, not significant.